Alkem Laboratories Limited
ICICI Prudential Mutual Fund bought 9,03,527 shares of Alkem Laboratories for ₹469.83 Cr at ₹5200 apiece in a block deal.
A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.